Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study
These results of this proof-of-concept study support not only the safety of DNA vaccine immunotherapy in dogs with AD, but also its potential clinical benefits. A double-blinded, ≥ 12 month long, controlled study with more subjects should follow to further confirm the true efficacy of this vaccine.
Authors
- Shoji Ogino
- Chigusa Matsumoto
- Toshihiro Tsukui (ORCID: https://orcid.org/0000-0001-8830-5930)
- Petra Bizikova (ORCID: https://orcid.org/0000-0001-8629-0528)
- Ina Herrmann (ORCID: https://orcid.org/0000-0003-2772-9144)
- Kim R. Love
- M. Lois Murphy
Institutions
- North Carolina State University (US)
Publication Details
- Journal
- Veterinary Dermatology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1111/vde.70037
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00